| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2024 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | UG3DA059286 | A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body | 000 | 2 | NIH | 12/10/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $5,336,671 ) |
| | 2025 | 2025 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | U01DA058548 | Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 003 | 3 | NIH | 7/16/2025 | $3,799,875 |
| | 2025 | 2025 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | R44DA056272 | A Novel Reversal Agent for Treatment of Overdose from the Combination of Fentanyl and Xylazine | 001 | 3 | NIH | 7/24/2025 | $1,536,796 |
| | 2025 | 2024 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | UG3DA059286 | A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body | 000 | 2 | NIH | 9/18/2025 | $0 |
| | 2025 | 2024 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | R44DA056272 | A Novel Reversal Agent for Treatment of Overdose from the Combination of Fentanyl and Xylazine | 000 | 2 | NIH | 10/24/2024 | $0 |
| | 2025 | 2024 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | U01DA058548 | Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 001 | 2 | NIH | 3/17/2025 | $0 |
| | 2025 | 2024 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | U01DA058548 | Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 002 | 2 | NIH | 4/22/2025 | $0 |
| | 2025 | 2024 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | U01DA058548 | Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 000 | 2 | NIH | 11/1/2024 | $0 |
| | 2025 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | U01DA053054 | Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 000 | 3 | NIH | 11/20/2024 | $0 |
| | 2025 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | U01DA053054 | Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 001 | 3 | NIH | 12/9/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $8,607,397 ) |
| | 2024 | 2024 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | UG3DA059286 | A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body | 002 | 2 | NIH | 8/6/2024 | $3,051,790 |
| | 2024 | 2024 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | R44DA056272 | A Novel Reversal Agent for Treatment of Overdose from the Combination of Fentanyl and Xylazine | 000 | 2 | NIH | 8/1/2024 | $1,462,687 |
| | 2024 | 2024 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | U01DA058548 | Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 001 | 2 | NIH | 8/28/2024 | $4,092,920 |
| | 2024 | 2023 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | UG3DA059286 | A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body | 001 | 1 | NIH | 6/5/2024 | $0 |
| | 2024 | 2023 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | UG3DA059286 | A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body | 000 | 1 | NIH | 10/31/2023 | $0 |
| | 2024 | 2023 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | U01DA058548 | Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 000 | 1 | NIH | 10/31/2023 | $0 |
| | 2024 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | R44DA052957 | Novel Therapeutic Agents to Reverse Opioid Overdose | 000 | 3 | NIH | 8/29/2024 | $0 |
| | 2024 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | U01DA053054 | Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 000 | 3 | NIH | 2/7/2024 | $0 |
| | 2024 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | R43DA057782 | An oral therapeutic to treat intoxication by prescription and illicit stimulants | 000 | 1 | NIH | 12/14/2023 | $0 |
| | 2024 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138-1002 | MIDDLESEX | USA | R43DA056272 | A novel therapeutic approach for treatment of acute intoxication by co-use of opioids and stimulants | 000 | 1 | NIH | 11/16/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $7,105,785 ) |
| | 2023 | 2023 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | UG3DA059286 | A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body | 001 | 1 | NIH | 9/20/2023 | $0 |
| | 2023 | 2023 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | UG3DA059286 | A Therapeutic Agent to Lower the Level of Synthetic Opioids in the Body | 000 | 1 | NIH | 8/22/2023 | $3,035,865 |
| | 2023 | 2023 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | U01DA058548 | Clinical Development of a Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 000 | 1 | NIH | 8/15/2023 | $4,069,920 |
| | 2023 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | U01DA053054 | Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 001 | 3 | NIH | 3/10/2023 | $0 |
| | 2023 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R43DA057782 | An oral therapeutic to treat intoxication by prescription and illicit stimulants | 000 | 1 | NIH | 12/15/2022 | $0 |
| | 2023 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | U01DA053054 | Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 000 | 3 | NIH | 11/15/2022 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $5,952,476 ) |
| | 2022 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R43DA056272 | A novel therapeutic approach for treatment of acute intoxication by co-use of opioids and stimulants | 000 | 1 | NIH | 6/23/2022 | $319,695 |
| | 2022 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R43DA057782 | An oral therapeutic to treat intoxication by prescription and illicit stimulants | 000 | 1 | NIH | 9/22/2022 | $319,946 |
| | 2022 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R44DA052957 | Novel Therapeutic Agents to Reverse Opioid Overdose | 001 | 3 | NIH | 8/24/2022 | $1,245,607 |
| | 2022 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | U01DA053054 | Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 003 | 3 | NIH | 6/30/2022 | $0 |
| | 2022 | 2022 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | U01DA053054 | Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 001 | 3 | NIH | 6/16/2022 | $4,067,228 |
| | 2022 | 2021 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | U01DA053054 | Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 002 | 2 | NIH | 6/29/2022 | $0 |
| | 2022 | 2021 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R44DA052957 | Novel Therapeutic Agents to Reverse Opioid Overdose | 000 | 2 | NIH | 4/15/2022 | $0 |
| | 2022 | 2021 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | U01DA053054 | Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 000 | 2 | NIH | 10/12/2021 | $0 |
|
| Issue Date FY: 2021 ( Subtotal = $5,340,447 ) |
| | 2021 | 2021 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | U01DA053054 | Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 002 | 2 | NIH | 9/20/2021 | $114,933 |
| | 2021 | 2021 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | U01DA053054 | Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 001 | 2 | NIH | 6/9/2021 | $3,941,786 |
| | 2021 | 2021 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R44DA052957 | Novel Therapeutic Agents to Reverse Opioid Overdose | 000 | 2 | NIH | 9/22/2021 | $1,283,727 |
| | 2021 | 2021 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R44DA052957 | Novel Therapeutic Agents to Reverse Opioid Overdose | 001 | 2 | NIH | 9/25/2021 | $1 |
| | 2021 | 2020 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | U01DA053054 | Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 000 | 1 | NIH | 4/28/2021 | $0 |
| | 2021 | 2020 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R43DA052957 | Novel Therapeutic Agents to Reverse Opioid Overdose | 001 | 1 | NIH | 7/31/2021 | $0 |
| | 2021 | 2020 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R43DA052957 | Novel Therapeutic Agents to Reverse Opioid Overdose | 000 | 1 | NIH | 1/5/2021 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $4,157,125 ) (Continued on the next page) |
| | 2020 | 2020 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | R43DA052957 | Novel Therapeutic Agents to Reverse Opioid Overdose | 000 | 1 | NIH | 9/21/2020 | $224,889 |
| | 2020 | 2020 | CLEAR SCIENTIFIC, LLC | 737 CONCORD AVE | CAMBRIDGE | MA | 02138 | MIDDLESEX | USA | U01DA053054 | Therapeutic Agent for Rapid Reversal of Methamphetamine Intoxication | 001 | 1 | NIH | 9/25/2020 | $0 |
|
